Craft

Rhinomed

Revenue

$7.5 M

FY, 2023

Rhinomed Summary

Company Summary

Overview
Rhinomed is an airway technology company that is engaged in the research, development, and commercialization of consumer and medical devices. It offers sports breathing technology. The company also provides solutions for sleep, diagnostics, and clinical program.
Type
Private
Status
Active
Founded
2013
HQ
Cremorne, AU | view all locations
Website
https://www.rhinomed.global/
Cybersecurity rating
Sectors

Key People

  • Michael Johnson

    Michael Johnson, Managing Director & CEO

  • Ron Dewhurst, Chairman

    • John McBain Ao, Non Executive Director

    • Lyn Swinburne Ao

      Lyn Swinburne Ao, Non Executive Director

    LocationsView all

    2 locations detected

    • Cremorne, VIC HQ

      Australia

      Suite 1/132 Gwynne St

    • New York, NY

      United States

      41 Madison Ave 31st Floor

    Rhinomed Financials

    Summary Financials

    Revenue (FY, 2023)
    $7.5M
    Gross profit (FY, 2023)
    $6.2M
    Net income (FY, 2023)
    ($11.1M)
    Cash (FY, 2023)
    $190.0K
    EBIT (FY, 2023)
    ($11.2M)

    Footer menu